Prestige Consumer Healthcare PBH Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.
The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net?
- Prestige Consumer Healthcare (PBH) reported debt - unamortized discount (premium) and issuance costs, net of $6.45M in Q4 2025.
- How has Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net decreased by 19.6% year-over-year, from $8.03M to $6.45M.
- What is the long-term trend for Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net?
- Over 4 years (2021 to 2025), Prestige Consumer Healthcare's debt - unamortized discount (premium) and issuance costs, net has grown at a -16.0% compound annual growth rate (CAGR), from $15.35M to $7.64M.
- What does debt - unamortized discount (premium) and issuance costs, net mean?
- This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.